TAUROURSODEOXYCHOLIC ACID

• CAT Number: M056099
• CAS Number: 14605-22-2
• Molecular Formula: C26H45NO6S
• Molecular Weight: 499.71
• Purity: 98%
• Synonyms: 3α,7β-dihydroxy-5β-cholanoyl Taurine;TUDCA;UR-906
• Target: tyrB ITGA5
• Target Protein: P08648
• Appearance: Solid
• Storage: Dry, dark and at 2 - 8 °C for six months or -20°C for two years.
• IUPAC Name: 2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
• InChI: InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22+,24+,25+,26-/m1/s1
• InChIKey: BHTRKEVKTKCXOH-LBSADWJPSA-N
• SMILES: C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C

Tauroursodeoxycholic acid (Cat No.:M056099) is a bile acid derivative used for the treatment of liver disorders, such as cholestasis and primary biliary cirrhosis. It is the taurine-conjugated form of ursodeoxycholic acid (UDCA) and works by protecting liver cells from bile acid-induced apoptosis and reducing bile toxicity. TUDCA has anti-inflammatory and anti-apoptotic properties, which help maintain liver function and promote bile flow. Additionally, it shows potential in treating neurodegenerative diseases due to its cytoprotective effects on cells. TUDCA is a valuable therapeutic for liver protection and overall cellular health.